Nazmul Kabir Qureshi

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Topics

Coronavirus Disease

Insulin Resistance

Top Venues

Diabetes, metabolic syndrome and obesity : targets and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

M D Faruque Pathan, Nazma Akter, Shahjada Selim, M Saifuddin, Nazmul Kabir Qureshi, A B M Kamrul-Hasan, Mohammad Abdul Hannan, Md Ashraf Uddin Ahmed, Marufa Mustari, Ashish Kumar Chakraborty
Efficacy and Safety of Empagliflozin in Patients with Type 2 Diabetes Mellitus Fasting During Ramadan: A Real-World Study from Bangladesh. Diabetes, metabolic syndrome and obesity : targets and therapy 15 (2022)
M D Faruque Pathan, Nazma Akter, Shahjada Selim, M Saifuddin, Nazmul Kabir Qureshi, A B M Kamrul-Hasan, Mohammad Abdul Hannan, Md Ashraf Uddin Ahmed, Marufa Mustari, Ashish Kumar Chakraborty
Efficacy and Safety of Empagliflozin in Patients with Type 2 Diabetes Mellitus Fasting During Ramadan: A Real-World Study from Bangladesh. Diabetes, metabolic syndrome and obesity : targets and therapy 15 (2022)
Faruque Pathan, Shahjada Selim, Md Fariduddin, Md Hafizur Rahman, S M Ashrafuzzaman, Faria Afsana, Nazmul Kabir Qureshi, Tanjina Hossain, M Saifuddin, A B M Kamrul-Hasan, Ahmed Salam Mir, null null
Bangladesh Endocrine Society (BES) Position Statement for Management of Diabetes and Other Endocrine Diseases in Patients with COVID-19. Diabetes, metabolic syndrome and obesity : targets and therapy 14 (2021)